These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5602628)

  • 1. [Action of a uricemic depressor (allopurinol) co-administered with a diuretic (chlorthalidon) to gout patients].
    Chegoriansky J; Piterbarg R; Catoggio PM
    Prensa Med Argent; 1967 Apr; 54(9):429-32. PubMed ID: 5602628
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term treatment of 20 cases of gout with allopurinol].
    Yoshimura T; Akaoka I; Nishizawa T; Nishida T
    Ryumachi; 1973 Apr; 13(2):168-82. PubMed ID: 4730440
    [No Abstract]   [Full Text] [Related]  

  • 3. [Allopurinol in the treatment of gout].
    Klein G; Griendl W; Kalb R
    Z Rheumaforsch; 1968 Dec; 27(11):455-60. PubMed ID: 5710881
    [No Abstract]   [Full Text] [Related]  

  • 4. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of Milurit in the treatment of gout].
    Chodorowski Z; Muszkowska-Penson J; Spineter E; Natoński A; Michowska M; Manitius A
    Pol Tyg Lek; 1974 Dec; 29(48):2093-5. PubMed ID: 4438166
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanism of the action of allopurinol].
    Pikhlak EG; Piliaev VG
    Sov Med; 1981; (10):111-4. PubMed ID: 7031905
    [No Abstract]   [Full Text] [Related]  

  • 8. [Early diagnosis and early treatment of gout].
    Mertz DP
    Hippokrates; 1968 Jan; 39(1):5-12. PubMed ID: 5667616
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful desensitisation of allopurinol-induced erythema multiforme.
    Fonseka MM; Sathischandra H; Jayamanne SF; de Silva HJ
    Ceylon Med J; 1999 Dec; 44(4):190-1. PubMed ID: 10895280
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications for and methods of allopurinol-benzbromarone combination therapy in the treatment of hyperuricemic metabolic disorders].
    Heidelmann G; Burck G; Dauterstedt W; Heinrich JJ; Ohlmer R
    Z Arztl Fortbild (Jena); 1982 Mar; 76(5):177-81. PubMed ID: 6896252
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of benzbromarone and allopurinol on adiponectin in vivo and in vitro.
    Inokuchi T; Tsutsumi Z; Takahashi S; Ka T; Yamamoto A; Moriwaki Y; Masuzaki H; Yamamoto T
    Horm Metab Res; 2009 Apr; 41(4):327-32. PubMed ID: 19048458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allopurinol induced generalized eosinophilic pustular folliculitis.
    Ooi CG; Walker P; Sidhu SK; Gordon LA; Marshman G
    Australas J Dermatol; 2006 Nov; 47(4):270-3. PubMed ID: 17034470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of allopurinol on plasma lipid fractions in gout patients].
    Giovannelli G; Carcassi A; Gragnoli G; Marcolongo R; Pupillo A
    Atti Accad Fisiocrit Siena Med Fis; 1967; 16(2):1011-24. PubMed ID: 5621168
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone].
    Matzkies F
    Fortschr Med; 1983 May; 101(20):953-9. PubMed ID: 6873850
    [No Abstract]   [Full Text] [Related]  

  • 16. [Allopurinol in the treatment of gout].
    Isomäki H; Kemilä S
    Duodecim; 1968; 84(17):975-80. PubMed ID: 5704850
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinstitution of allopurinol therapy for gouty arthritis after cutaneous reactions.
    Fam AG; Paton TW; Chaiton A
    Can Med Assoc J; 1980 Jul; 123(2):128-9. PubMed ID: 6455189
    [No Abstract]   [Full Text] [Related]  

  • 19. [Allopurinol in the treatment of gout. Preliminary report].
    Lignière GC; Cirla E
    Reumatismo; 1968; 20(2):101-3. PubMed ID: 5748155
    [No Abstract]   [Full Text] [Related]  

  • 20. Febuxostat: new drug. Hyperuricaemia: risk of gout attacks.
    Prescrire Int; 2009 Apr; 18(100):63-5. PubMed ID: 19585722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.